This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Vapotherm 과거 수익 실적

과거 기준 확인 0/6

Vapotherm의 수입은 연평균 -10.3%의 비율로 감소해 온 반면, Medical Equipment 산업은 수입이 연평균 12%의 비율로 증가했습니다. 매출은 연평균 0.4%의 비율로 감소해 왔습니다.

주요 정보

-10.3%

수익 성장률

9.4%

EPS 성장률

Medical Equipment 산업 성장	8.9%
매출 성장률	-0.4%
자기자본 수익률	n/a
순이익	-76.7%
최근 수익 업데이트	30 Jun 2024

최근 과거 실적 업데이트

Recent updates

Vapotherm announces $23M private placement

Feb 08

Vapotherm GAAP EPS of -$0.98 misses by $0.20, revenue of $13.5M misses by $3.02M

Nov 02

The Independent Director of Vapotherm, Inc. (NYSE:VAPO), Anthony Arnerich, Just Bought 59% More Shares

Mar 12

Announcing: Vapotherm (NYSE:VAPO) Stock Increased An Energizing 225% In The Last Year

Mar 11

Does Vapotherm (NYSE:VAPO) Have A Healthy Balance Sheet?

Jan 19

Vapotherm guides Q4 revenue above consensus, ~212% Y/Y growth

Jan 13

Thomas Smith of Vapotherm, Inc. (NYSE:VAPO) Just Spent US$217k On Shares

Dec 14

Investors Who Bought Vapotherm (NYSE:VAPO) Shares A Year Ago Are Now Up 132%

Dec 11

Vapotherm shares +9% on higher Q4 guidance

Dec 01

Vapotherm: The Game Has Completely Changed

Nov 13

수익 및 비용 분석

Vapotherm 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

OTCPK:VAPO 수익, 비용 및 수입 (USD Millions )
날짜	수익	수익	G+A 비용	R&D 비용
30 Jun 24	71	-54	45	13
31 Mar 24	70	-55	48	14
31 Dec 23	69	-58	52	14
30 Sep 23	68	-69	58	15
30 Jun 23	66	-81	65	17
31 Mar 23	63	-108	68	19
31 Dec 22	67	-113	75	20
30 Sep 22	70	-110	80	21
30 Jun 22	95	-98	89	20
31 Mar 22	103	-72	94	19
31 Dec 21	113	-60	93	18
30 Sep 21	132	-58	99	18
30 Jun 21	124	-57	92	19
31 Mar 21	139	-48	92	19
31 Dec 20	126	-52	89	17
30 Sep 20	98	-47	76	16
30 Jun 20	78	-47	67	14
31 Mar 20	55	-52	60	13
31 Dec 19	48	-51	56	13
30 Sep 19	47	-51	54	12
30 Jun 19	45	-48	51	11
31 Mar 19	44	-47	49	10
31 Dec 18	42	-43	45	9
30 Sep 18	41	-39	42	8
30 Jun 18	40	-37	39	8
31 Mar 18	38	-33	36	8
31 Dec 17	36	-31	34	8
31 Dec 16	30	-23	26	6

양질의 수익: VAPO 은(는) 현재 수익성이 없습니다.

이익 마진 증가: VAPO 은(는) 현재 수익성이 없습니다.

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: VAPO 은(는) 수익성이 없으며 지난 5년 동안 연간 10.3% 비율로 손실이 증가했습니다.

성장 가속화: 현재 수익성이 없기 때문에 VAPO 의 지난 1년 동안의 수익 성장을 5년 평균과 비교할 수 없습니다.

수익 대 산업: VAPO 은(는) 수익성이 없어 지난 해 수익 성장을 Medical Equipment 업계( 10.4% )와 비교하기 어렵습니다.

자기자본 수익률

높은 ROE: VAPO 의 부채가 자산을 초과하므로 자기자본수익률을 계산하기 어렵습니다.

This company has been acquired

Vapotherm 과거 수익 실적

과거 기준 확인 0/6

주요 정보

최근 과거 실적 업데이트

Vapotherm, Inc. to Report Q3, 2023 Results on Nov 08, 2023

Vapotherm, Inc. to Report Q2, 2023 Results on Aug 08, 2023

Vapotherm, Inc. Reports Impairment of Long-Lived and Intangible Assets for the First Quarter Ended March 31, 2023

Vapotherm, Inc. to Report Q4, 2022 Results on Feb 23, 2023

Vapotherm, Inc. to Report Q3, 2022 Results on Nov 02, 2022

Vapotherm, Inc. Reports Unaudited Condensed Consolidated Impairment Charges for the Second Quarter Ended June 30, 2022

Recent updates

Perceptive Discovery Fund LP, managed by Perceptive Advisors LLC completed the acquisition of Vapotherm, Inc. (OTCPK:VAPO) from a group of shareholders.

Perceptive Discovery Fund LP, managed by Perceptive Advisors LLC entered into definitive merger agreement to acquire Vapotherm, Inc. (OTCPK:VAPO) for $15.1 million.

Vapotherm, Inc. to Unveil Access365 Home Ventilation Solution at MEDTRADE

The New York Stock Exchange to Commence Delisting Proceedings against Vapotherm

Vapotherm, Inc. Revises Revenue Guidance for the Full Year 2023

Vapotherm, Inc. to Report Q3, 2023 Results on Nov 08, 2023

Vapotherm Announces Presentation of an Investigator-Initiated Clinical Trial, 'High Flow Humidified Oxygen as an Early Intervention in Children with Acute Severe Asthma - a Feasibility Randomized Controlled Trial' at the European Respiratory Society International Congress 2023

Vapotherm, Inc. Revises Earnings Guidance for Fiscal 2023

Vapotherm, Inc. to Report Q2, 2023 Results on Aug 08, 2023

Vapotherm, Inc. Reports Impairment of Long-Lived and Intangible Assets for the First Quarter Ended March 31, 2023

Vapotherm Receives Price Cure Notification Letter from the NYSE Indicates its Stock Price Above the NYSE's Minimum Requirement

Vapotherm, Inc. to Report Q4, 2022 Results on Feb 23, 2023

Vapotherm announces $23M private placement

Vapotherm, Inc. Provides Revenue Guidance for the Fourth Quarter of 2022

Vapotherm, Inc. Provides Revenue Guidance for 2022

Vapotherm GAAP EPS of -$0.98 misses by $0.20, revenue of $13.5M misses by $3.02M

Vapotherm, Inc. to Report Q3, 2022 Results on Nov 02, 2022

Vapotherm Announces NYSE Continued Listing Standard Notice

Vapotherm draws downgrade at William Blair after 2Q results

Vapotherm, Inc. Reports Unaudited Condensed Consolidated Impairment Charges for the Second Quarter Ended June 30, 2022

Vapotherm, Inc. to Report Q2, 2022 Results on Aug 03, 2022

Vapotherm, Inc. Plans to Move All of Its Manufacturing Operations from New Hampshire to Mexico

Price target decreased to US$4.83

Vapotherm, Inc.(NYSE:VAPO) dropped from Russell 2000 Growth Index

Vapotherm: Out Of Air

Vapotherm, Inc. Revises Earnings Guidance for the Fiscal Year 2022

Vapotherm, Inc., Annual General Meeting, Jun 21, 2022

Vapotherm, Inc. Provides Revenue Guidance for the First Quarter of 2022

Consensus forecasts updated

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Price target decreased to US$34.33

Vapotherm, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year 2022

Vapotherm, Inc. to Report Q4, 2021 Results on Feb 24, 2022

Is Vapotherm (NYSE:VAPO) Using Too Much Debt?

Vapotherm, Inc. Announces Revenue Guidance for the Fourth Quarter of 2021, Full Year 2021 and 2022

Third quarter 2021 earnings released: US$0.52 loss per share (vs US$0.49 loss in 3Q 2020)

Chief Accounting Officer Joel Dube has left the company

Vapotherm, Inc. Revises Revenue Guidance for the Fiscal Year 2021

Vapotherm, Inc. Announces FDA 510(k) Clearance for HVT 2.0 Next Generation Platform

Senior VP notifies of intention to sell stock

Second quarter 2021 earnings released: US$0.67 loss per share (vs US$0.35 loss in 2Q 2020)

Senior VP & Chief Commercial Officer exercised options and sold US$170k worth of stock

Vapotherm: Hardly Breathing Room

Insider recently bought US$4.8m worth of stock

Independent Director Marina Hahn has left the company

Independent Chairman of the Board recently bought US$170k worth of stock

Health Check: How Prudently Does Vapotherm (NYSE:VAPO) Use Debt?

First quarter 2021 earnings released: US$0.40 loss per share (vs US$0.66 loss in 1Q 2020)

Vapotherm, Inc. Provides Financial Guidance for 2021

Vapotherm reports Q1 results

The Independent Director of Vapotherm, Inc. (NYSE:VAPO), Anthony Arnerich, Just Bought 59% More Shares

Independent Director recently bought US$109k worth of stock

Announcing: Vapotherm (NYSE:VAPO) Stock Increased An Energizing 225% In The Last Year

Full year 2020 earnings released: US$2.16 loss per share (vs US$2.74 loss in FY 2019)

Revenue and earnings beat expectations

New 90-day low: US$23.17

Vapotherm, Inc. to Report Q4, 2020 Results on Feb 24, 2021

Senior VP & Chief Commercial Officer notifies of intention to sell stock

Senior VP & Chief Commercial Officer exercised options and sold US$56k worth of stock

Does Vapotherm (NYSE:VAPO) Have A Healthy Balance Sheet?

Vapotherm guides Q4 revenue above consensus, ~212% Y/Y growth

New 90-day high: US$32.08

Thomas Smith of Vapotherm, Inc. (NYSE:VAPO) Just Spent US$217k On Shares

Insider recently bought US$217k worth of stock

Investors Who Bought Vapotherm (NYSE:VAPO) Shares A Year Ago Are Now Up 132%

Analysts update estimates

Vapotherm, Inc. Revises Revenue Guidance for the Fourth Quarter and Full Year 2020

Vapotherm shares +9% on higher Q4 guidance